"""Keep away from chemotherapy""may not just a dream for lymphoma:review new data from the 54th ASH annual meeting"
10.3760/cma.j.issn.1009-9921.2013.03.001
- VernacularTitle:淋巴瘤无需化疗的梦想何时实现:2012年第54届美国血液学会年会随想
- Author:
Jun ZHU
;
Yuqin SONG
;
Lijuan DENG
;
Ningjing LIN
- Publication Type:Journal Article
- Keywords:
Lymphoma;
Targeted therapy;
ASH annual meeting
- From:
Journal of Leukemia & Lymphoma
2013;22(3):129-131
- CountryChina
- Language:Chinese
-
Abstract:
The 54th ASH annual meeting should be considered as a revolution for treatment of lymphoma.Keep away from chemotherapy will not be just a dream,it based on the deep understand of lymphoma genesis and quick development of different targeted agents.The typical examples are the dramatic novel agents targeting B cell receptor signaling pathway and microenvironment.There combination,such as R-square regimen,showed unbelievable efficacy in indolent B cell lymphomas and tiny side effects.It is sure that therapy breakthroughs in aggressive B cell lymphomas and T/NK cell lymphomas are in the very near future.
